Navigation Links
Dendreon in Medical News

GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN

... Generex Biotechnology, Corp. (Nasdaq: GNBT ), Cell Therapeutics, Inc. (Nasdaq: CTIC ), Cancer Therapeutics Inc. (OTC Bulletin Board: CTHP), & dendreon Corp. (Nasdaq: DNDN ). GlobalEquityReport.com alerts its members daily on stocks that are hot in the market. These include stocks with huge...

Dendreon Corp. (Nasdaq: DNDN) - Prostate Cancer Patients Benefit

...lk section , posted a Special Technical Report on dendreon Corporation (Nasdaq: DNDN ), which we have been ...ge of 4.1 months. According to published analysts, dendreon should be able to file for regulatory approval dur...roval during the first half of 2010. This is dendreon Corp (DNDN):...

Defined Health Announces Final Speaker Roster and Agenda for Therapeutic Insight 2008

...ode Debrabandere, PhD, Vice President & General Manager Inflammatory Diseases, Osiris * Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, dendreon Corporation * Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma * Milton H. Grannatt, PhD, Vice President and Head, Negotiation...

Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer

...ics for the treatment of cancer with technology licensed from Fred Hutchinson Cancer Research Center. From 2000 to 2005, Mr. Pickering was employed by dendreon Corporation in Seattle, Washington and served as a Corporate Officer and most recently as its Senior Vice President of Operations. During his tenure a...

Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board

...ce Committees of the Board of Directors. Mrs. Bayh currently serves on the boards of directors of Curis, Inc., a therapeutic drug development company, dendreon Corporation, a therapeutic drug development company, Dyax Corp., a biopharmaceutical company, Emmis Communications, a diversified media company, and W...

-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET-

... SEATTLE, Nov. 2 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) will release its third ...g for 30 days at http://www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...

WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business

...g companies based in San Francisco. The new hires include seasoned corporate communications and investor relations experts Monique Greer, formerly of dendreon Corporation, and Nicole Foderaro, formerly of Nuvelo, Inc. In addition, several other associates have joined its offices across the country, including...
Dendreon in Medical Technology

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

...GO and SEATTLE, April 28 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that... and specifications outlined in its SPA agreement, dendreon intends to file an amendment to its existing Biolo...nference Call Scheduled for Today at 5:30 pm ET dendreon will host a conference call today at 5:30 pm ET. T...

Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia

...pril 28 /PRNewswire-FirstCall/ -- Researchers from dendreon Corporation (Nasdaq: DNDN ) today presented prec...se and key role in cell biology and in pathology. dendreon has synthesized small molecule agonists including ...8 ion channel and induce cell death. About dendreon ...

Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer

... SEATTLE, April 21 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...se and key role in cell biology and in pathology. dendreon has synthesized small molecule agonists including ...8 ion channel and induce cell death. About dendreon ...

CEL-SCI Corporation Releases Letter to Shareholders

...ortant event has just transpired for our company. dendreon Corporation has announced that its pivotal Phase I...ssible to be heard. The successful outcome of the dendreon study gives the cancer immunotherapy field the nee...to attract new money to the space. The success of dendreon proves that it is possible to harness the human im...

Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial

... SEATTLE, April 13 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) will host a conferen...ing for 30 days at www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...

Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium

... SEATTLE, Nov. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) today will present a su...s a complete course of therapy. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...

Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial

...oday - SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) announced today that it...ndent data monitoring committee (IDMC) reported to dendreon a 20 percent reduction in the risk of death in the...ed, metastatic prostate cancer. About Dendreon dendreon Corporation is a biotechnology company whose missi...

Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial

... SEATTLE, Oct. 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN) will host a conference ...s at http://www.dendreon.com . About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...

Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October

... SEATTLE, July 23 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that ...riterion for statistical significance be achieved, dendreon would anticipate amending its Biologics License Ap...ancer with a primary endpoint of overall survival. dendreon is conducting the IMPACT trial under a Special Pro...

Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery

... SEATTLE, July 16 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that ...al, combined with low toxicity. About Dendreon dendreon Corporation is a biotechnology company whose missi...ndidates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...
Dendreon in Biological Technology

Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET

... SEATTLE, July 30 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) management will host...or 30 days at www.dendreon.com . About dendreon dendreon Corporation is a biotechnology company whose missi...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

..., Bristol-Myers Squibb Company, Cell Genesys Inc., dendreon Corporation, EUSA Pharma, (USA) Inc., F. Hoffmann-...n with Seattle Genetics II-80 Diosynth and dendreon Sign Multi-Year Commercial Supply Deal II-80 G... Products to Treat Prostate Diseases II-84 dendreon Constructs Manufacturing Facility in New Jersey II...

CEL-SCI Corporation Releases Letter to Shareholders

...n 12% of the patients after only a 3-week treatment. The recent success of dendreon with its prostate cancer vaccine has shown that it is possible to stimulate the immune system of cancer patients to increase survival. dendreon went from about $3 to $27 on that news. The validation of the manufacturin...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

... SEATTLE, June 5 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...rom Dendreon's website, www.dendreon.com . dendreon Corporation is a biotechnology company whose missi...didates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...

Biotech Shows Glimmer of an Upward Trend

...at they don't lose out to their competitors," added Burrill. Shares of dendreon have increased in value by a whopping 440 percent since the company first a...dvanced prostate cancer by an average of 4.1 months. According to analysts, dendreon should be able to file for regulatory approval during the fourth quarter 20...

Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest

... SEATTLE, May 14 /PRNewswire-FirstCall/ -- dendreon Corporation today announced that Chief Executive O...Seattle Business and The Summit Group. About dendreon dendreon Corporation is a biotechnology company whose missi...

Dendreon Announces Closing of Common Stock Offering

... SEATTLE, May 13 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) announced today the ...gregate of 11,979,166 shares of common stock. dendreon received net proceeds from the offering of approxi...ting commissions and estimated offering expenses. dendreon plans to use the net proceeds of the offering to d...

Dendreon Announces Common Stock Offering

... SEATTLE, May 8 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) announced today the ...rities will act as sole manager for the offering. dendreon has granted Deutsche Bank Securities an option t...mon stock to cover over-allotments, if any. dendreon intends to use the net proceeds of the offering to...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

... SEATTLE, May 7 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today announced that...rom Dendreon's website, www.dendreon.com . dendreon Corporation is a biotechnology company whose missi...didates designed to stimulate an immune response. dendreon is also developing an orally-available small molec...

Dendreon Reports First Quarter 2009 Financial Results

... SEATTLE, May 6 /PRNewswire-FirstCall/ -- dendreon Corporation (Nasdaq: DNDN ) today reported resul...erence on May 20, 2009 About dendreon dendreon Corporation is a biotechnology company whose missi...
Other Tags
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today, UWDress.com, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. , UWDress.com’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
(Date:12/19/2014)... and Markets ( http://www.researchandmarkets.com/research/8kmfcn/iphone_5s ) has announced ... - Apple/AuthenTec TMDR92 & Sapphire - Technology Report" ... http://photos.prnewswire.com/prnh/20130307/600769 Following the acquisition of AuthenTec ... with the iPhone 5S. It is currently the only ...
(Date:12/19/2014)... 18, 2014  23andMe, Inc., the leading personal genetics company, today ... in genetic ancestry of individuals from across the ... more than four hundred years ago, the United ... peoples from different continents. This study illuminates how American history ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... "Samsung Galaxy S5 - Home Button Synaptics Fingerprint ... http://photos.prnewswire.com/prnh/20130307/600769 Based ... 5S, Samsung introduces for the first time a fingerprint ...
Breaking Biology News(10 mins):iPhone 5S Fingerprint Sensor - Apple/AuthenTec TMDR92 & Sapphire - Technology Report 223andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
Other Contents